Prot #R475-PN-1524: A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain
- Schnitzer, Thomas J (PD/PI)
Project: Research project